SAB Biotherapeutics
SABS
SABS
34 hedge funds and large institutions have $56.3M invested in SAB Biotherapeutics in 2025 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
36% more funds holding
Funds holding: 25 → 34 (+9)
Holders
34
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$25.8M | |
| 2 | +$9.95M | |
| 3 | +$9.95M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$6.45M |
| 5 |
SC
Sessa Capital
New York
|
+$3.93M |
Top Sellers
| 1 | -$29.9K | |
| 2 | -$20.8K | |
| 3 | -$7.2K | |
| 4 |
BlackRock
New York
|
-$1.51K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$255 |